These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33613729)

  • 1. Progress in drug delivery system for fibrosis therapy.
    Xing L; Chang X; Shen L; Zhang C; Fan Y; Cho C; Zhang Z; Jiang H
    Asian J Pharm Sci; 2021 Jan; 16(1):47-61. PubMed ID: 33613729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FibromiRs: translating molecular discoveries into new anti-fibrotic drugs.
    Pottier N; Cauffiez C; Perrais M; Barbry P; Mari B
    Trends Pharmacol Sci; 2014 Mar; 35(3):119-26. PubMed ID: 24560301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights on drug and gene delivery systems in liver fibrosis.
    Vyas K; Patel MM
    Asian J Pharm Sci; 2023 Mar; 18(2):100779. PubMed ID: 36845840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for anti-fibrotic therapies.
    Rosenbloom J; Mendoza FA; Jimenez SA
    Biochim Biophys Acta; 2013 Jul; 1832(7):1088-103. PubMed ID: 23266403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.
    Li LC; Kan LD
    J Ethnopharmacol; 2017 Feb; 198():45-63. PubMed ID: 28038955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-assembling peptide hydrogel-based drug co-delivery platform to improve tissue repair after ischemia-reperfusion injury.
    Liu S; Zhao M; Zhou Y; Li L; Wang C; Yuan Y; Li L; Liao G; Bresette W; Chen Y; Cheng J; Lu Y; Liu J
    Acta Biomater; 2020 Feb; 103():102-114. PubMed ID: 31843715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of receptor targeted hepatic stellate cell in treatment of liver fibrosis].
    Yang D
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):630-632. PubMed ID: 30317799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
    Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
    Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
    Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
    Li H
    J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo.
    Poosti F; Pham BT; Oosterhuis D; Poelstra K; van Goor H; Olinga P; Hillebrands JL
    Dis Model Mech; 2015 Oct; 8(10):1227-36. PubMed ID: 26112172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.
    Nanthakumar CB; Hatley RJ; Lemma S; Gauldie J; Marshall RP; Macdonald SJ
    Nat Rev Drug Discov; 2015 Oct; 14(10):693-720. PubMed ID: 26338155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis.
    Zhubanchaliyev A; Temirbekuly A; Kongrtay K; Wanshura LC; Kunz J
    Front Pharmacol; 2016; 7():462. PubMed ID: 27990121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel targeted therapies for the management of liver fibrosis.
    Trivella JP; Martin P; Carrion AF
    Expert Opin Emerg Drugs; 2020 Mar; 25(1):59-70. PubMed ID: 32098512
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanotechnology in Drug Delivery for Liver Fibrosis.
    Gu L; Zhang F; Wu J; Zhuge Y
    Front Mol Biosci; 2021; 8():804396. PubMed ID: 35087870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research hotspots and progress of hepatic fibrosis - 2019 viewpoints].
    Guo JS
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):401-402. PubMed ID: 31357751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research advances on baicalin and baicalein as potential therapeutic agents for fibrotic disease].
    Zhu QJ
    Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(7):1271-1276. PubMed ID: 29052385
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.